TuHURA Biosciences, Inc.
HURA
$2.16
-$0.43-16.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 52.78% | 84.95% | 82.33% | 39.98% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 49.10% | 60.95% | 68.06% | 39.59% | -- |
| Operating Income | -49.10% | -60.95% | -68.06% | -39.59% | -- |
| Income Before Tax | -31.57% | -38.60% | -59.44% | -60.20% | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -31.57% | -38.60% | -59.44% | -60.20% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -31.57% | -38.60% | -59.44% | -60.20% | -- |
| EBIT | -49.10% | -60.95% | -68.06% | -39.59% | -- |
| EBITDA | -49.43% | -61.63% | -69.17% | -40.50% | -- |
| EPS Basic | 52.58% | 58.34% | 52.74% | -22.15% | -- |
| Normalized Basic EPS | 53.21% | 60.22% | 58.58% | -0.53% | -- |
| EPS Diluted | 52.58% | 58.34% | 52.77% | -22.04% | -- |
| Normalized Diluted EPS | 53.21% | 60.22% | 58.58% | -0.53% | -- |
| Average Basic Shares Outstanding | 96.66% | 156.69% | 69.07% | 49.69% | -- |
| Average Diluted Shares Outstanding | 96.66% | 156.69% | 69.07% | 49.69% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -2.06% | -- | -- | -- | -- |